A new frontier in pain management: Targeting the brain’s own RNA
A study published in *Brain* reveals a novel molecular mechanism for pain hypersensitivity, centered on a long non-coding RNA (lncRNA) named Carip. Researchers found that Carip is highly expressed in a specific brain region, the lateral parabrachial nucleus (LPBN), which is integral to pain processing. In mouse models, thermal stimulation increased Carip levels, while genetically knocking it out elevated pain thresholds. The investigation uncovered that Carip knockout disrupts the delicate balance between neuronal excitation and inhibition in a key pain circuit by enhancing specific signaling pathways. Crucially, blocking this downstream cascade restored normal neuronal function and corrected the abnormal pain behaviors, pinpointing Carip and its associated molecular pathway as a potential target for future analgesic therapies.
Why it might matter to you: This research moves beyond traditional targets for analgesia, identifying a specific RNA molecule that modulates pain at a fundamental neural circuit level. For anesthesiologists and pain specialists, it highlights a potential future avenue for developing non-opioid, mechanism-based treatments for chronic pain conditions. Understanding these central nervous system pathways could inform strategies for perioperative pain control and the management of complex, treatment-resistant pain syndromes.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
